Despite decades of research, the X-chromosome’s impact on Alzheimer’s was largely ignored until now. Explore how seven newly discovered genetic loci could revolutionize our understanding of the disease.
Conventional investigations of the genetic contributors to Alzheimer’s disease (AD) risk and progression have ignored the role of the X-chromosome, primarily due to technical analysis limitations. To address these knowledge gaps, a recent study published in the journal Molecular Psychiatry leveraged extensive X-Chromosome-Wide Association Study (XWAS) data from 115,841 AD cases (including clinically diagnosed and proxy cases) and 613,671 controls to identify genetic signals indicative of AD pathophysiology.
The study considered three patterns of X-chromosome inactivation (XCI) in females (r-XCI, s-XCI, and e-XCI) and found no AD-associated genome-wide signals in the non-pseudoautosomal regions of the X-chromosome. Notably, the study identified seven loci with X-chromosome-wide significance thresholds that may contribute to AD-associated genes (e.g., FRMPD4, DMD, and WNK3), which were highlighted as essential targets for future research.
Background
Alzheimer’s disease (AD) is an age-associated neurodegenerative disorder characterized by progressive memory and cognitive decline. It remains the most common precursor to adult dementia, with hitherto no identified cure. Decades of research have highlighted several (>80) genetic contributors (loci) to AD risk. Unfortunately, traditional technical limitations have resulted in the X-chromosome being predominantly excluded from these investigations.
The X-chromosome comprises 5% of the genome, with previous research suggesting it contains up to 15% of known genetic intellectual disability-contributing genes. Significant sexual dimorphism (male versus female differences) in both X-chromosome properties (women have two X-chromosomes, while men have only one) and AD outcomes (women are at higher AD risk and live longer with AD than their male counterparts, while men demonstrate more rapid AD-associated cognitive decline) necessitates enhanced understanding of the X-chromosome’s role in AD risk and progression.
About the Study
The present study aimed to address gaps in our understanding of the X-chromosome’s role in AD risk and progression by using an in-depth X-Chromosome-Wide Association Study (XWAS). The study dataset was derived from 35 previous studies, two independent family cohorts, and two biobanks (UK Biobank [UKB] and FinnGen). It included 115,841 AD cases (52,214 clinically diagnosed and 55,868 proxy cases), AD-proxies (defined as ‘either parent demonstrating dementia’ in females, and ‘mothers demonstrating dementia’ in males), and 613,671 controls (55% women), all of whom were of European ancestry.
a Main analyses and b sensitivity analyses. Box colors indicate the approach: purple, green, orange and blue represent r-XCI, s-XCI, e-XCI and sex-stratified approaches, respectively. Boxes circled in red are the main r-XCI, s-XCI and e-XCI analyses. *Fixed effect meta-analysis with an inverse-variance weighted approach as implemented in METAL. **Sex-stratified models were adjusted on 1) principal components (PCs) and/or the genotyping center; 2) PCs, center and age; 3) PCs, center, age and APOE.
Following sensitivity analyses, 63,838 diagnosed AD cases and 806,335 controls were included for downstream analyses. The study further incorporated cerebrospinal fluid biomarker analyses (Aβ42 and pTau) and cognitive impairment assessments (Mini-Mental State Examination [MMSE]) in a subset of included participants (5,522 and 2,661, respectively). Notably, the study excluded pseudoautosomal regions from the analyses, primarily due to their exclusion from most participants’ genotyping chips.
Analytical computation included association tests carried out under three X-chromosome inactivation (XCI) regimes accounting for different female XCI states – 1. Random XCI (r-XCI), 2. Skewed XCI (s-XCI), and 3. Escape XCI (e-XCI). Researchers additionally conducted sex-stratified analyses to account for variability induced by XCI mechanisms, which could result in stronger-than-expected effect sizes in males. Stringent quality control measures and sensitivity analyses were applied to ensure high data reliability and to mitigate potential false negatives arising from biobank-specific methodological differences.
“To maintain balance around allelic dosage between the sexes, X-chromosome inactivation (XCI) occurs in females. This process is where one X chromosome is transcriptionally silenced during female development. The choice of the silenced copy is most often random (random XCI or r-XCI), but inactivation can also be skewed toward a specific copy (skewed XCI or s-XCI). Importantly, up to one‐third of X‐chromosome genes ‘escape’ inactivation and are expressed from both X‐chromosomes in female cells (escape XCI or e-XCI).”
Finally, genetic colocalization computations comparing study outcomes (identified genetic loci) with preexisting protein- and expression-quantitative trait loci (pQTL and eQTL, respectively) datasets were employed to identify traits and biomarkers representative of cognitive decline.
Study Findings
The XWAS analyses conducted herein identified 666,264 r-XCI, 442,001 e-XCI, and 438,420 s-XCI variants, of which 288,320, 276,902, and 263,169, respectively, were common (minor allele frequency [MAF] ≥ 1%). Notably, none of the approaches employed identified genome-wide significant signals, suggesting that the non-pseudoautosomal regions of the X-chromosome are devoid of common AD-associated genetic risk factors.
Seven loci with X-chromosome-wide significance thresholds were identified, including four common loci (Xp22.32, FRMPD4, DMD, and Xq25) and three rare loci (WNK3, PJA1, and DACH2). These loci are highlighted as targets for future investigation and may hold the key to discovering clinical, therapeutic, and pharmacological interventions against AD genesis and progression.
FRMPD4, a brain-expressed gene linked to cognitive reserve, showed particularly robust signals. In contrast, rarer variants such as those in PJA1 and DACH2 demonstrated poor data quality (e.g., sparse variant coverage and lower imputation quality), underscoring the need for methodological optimizations in future research.
Conclusions
The present study represents the largest XWAS on AD to date, analyzing data from over 115,000 cases and 613,000 controls. It presents the first attempt at accounting for X-chromosome complexities, such as variability in female XCI patterns and the limitations of biobank-specific methods. While no genome-wide significant associations were found, seven suggestive loci, including FRMPD4, DMD, and WNK3, were identified. In tandem with gene expression and epigenetic investigations, this study may form the basis of future clinical interventions against AD risk and progression.
- Le Borgne, J., Gomez, L., Heikkinen, S., Amin, N., Ahmad, S., Choi, S. H., Bis, J., Rodriguez, O. G., Kleineidam, L., Young, J., Tripathi, K. P., Wang, L., Varma, A., Damotte, V., De Rojas, I., Palmal, S., Lipton, R., Reiman, E., McKee, A., . . . Bellenguez, C. (2024). X‐chromosome-wide association study for Alzheimer’s disease. Molecular Psychiatry, 1-12. DOI: 10.1038/s41380-024-02838-5, https://www.nature.com/articles/s41380-024-02838-5
News
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
Nanoplastics with environmental coatings can sneak past the skin’s defenses
Plastic is ubiquitous in the modern world, and it's notorious for taking a long time to completely break down in the environment - if it ever does. But even without breaking down completely, plastic [...]
Chernobyl scientists discover black fungus feeding on deadly radiation
It looks pretty sinister, but it might actually be incredibly helpful When reactor number four in Chernobyl exploded, it triggered the worst nuclear disaster in history, one which the surrounding area still has not [...]
